Home » Topics » BioWorld Science

BioWorld Science
RSS

Results from first portion of phase I study of PRN-1371 in patients with solid tumors

May 27, 2019

NRD.E1 demonstrates promising safety and efficacy in proof-of-concept study

May 27, 2019

Long-term data presented from FORWARD-2 study of ALKS-5461

May 27, 2019

BLU-5937: P2X3 homotrimeric receptor antagonist with improved taste safety profile for cough

May 27, 2019

Cyxone to seek clearance for phase I study of MS drug candidate T20K

May 24, 2019

NIAID begins phase I/II study of RSV vaccines in children aged 6-24 months

May 24, 2019

SBIR grant supports Sentia's development of astressins for IBS

May 24, 2019

Synlogic enters collaboration with Roche to study SYNB-1891 with Tecentriq in advanced tumors

May 24, 2019

Bioimics identifies bacterial ribonuclease P inhibitors

May 24, 2019

FDA grants marketing authorization to Zika virus diagnostic test

May 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...